Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Despite lots of big lingering questions, many clinicians dont think it actually matters right now how GLP-1 interacts with brain receptors on a cellular level, says Laura Huckins, PhD, an associate professor of psychiatry at the Yale School of Medicine
ATTAIN-2 (NCT05872620) is a Phase 3, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of various doses of orforglipron with placebo in adults with obesity or overweight and type 2 diabetes
Having clear expectations and staying consistent with your dosage routine is key to seeing maximum results
Check the prescribing clinician's Ahpra registration via the online practitioner register
US$ 25.65
US$ 24.05
US$ 28.04
US$ 28.72
US$ 22.62
US$ 25.96
US$ 28.66
